Table 1.
logIC50 | IC50 (μM) | HS | ΔYa (%) | |
---|---|---|---|---|
9a | −6.17 ± 0.03 | 0.67 ± 0.04b | 1.5 ± 0.2 | 79 ± 9 |
9b | −5.69 ± 0.13 | 2.0 ± 0.6 | 1.0c | 39 ± 2 |
9c | −3.78 ± 0.07 | 165 ± 25 | 2.1 ± 0.5 | ~94d |
9d | – | >500 | NAe | NA |
9f | −5.23 ± 0.11 | 5.8 ± 1.5 | 2.3 ± 1.2 | 43 ± 3 |
9g | ~ −4.0d | ~ 99d | UDf | ~ 26d |
12 | – | >500 | NA | NA |
13 | −4.51 ± 0.06 | 31 ± 4 | 3.5 ± 1.2 | 53 ± 4 |
14 | −4.18 ± 0.17 | 66 ± 25 | 1.0c | 49 ± 5 |
17 | −3.80 ± 0.15 | 158 ± 55 | 1.0c | 62 ± 16 |
23 | −3.81 ± 0.13 | 154 ± 45 | 1.2 ± 0.3 | ~ 91d |
Logistic equation 1 was used to fit the dose-dependence of the residual thrombin activity to obtain logIC50, HS, Y0, and YM values for inhibition in 20 mM Tris-HCl buffer, pH 7.4, containing 100 mM NaCl, 2.5 mM CaCl2, and 0.1% PEG8000 at 25 °C (see ‘Experimental Procedures’). ΔY = YM − Y0.
Errors represent ± 1 S. E.
HS was fixed to 1.0 to define the inhibition parameters better.
Approximate value because either HS, YM or Y0 was not defined well.
Not applicable.
Undefined.